Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.89 -0.47 (-0.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Non-Current Debt (2019 - 2026)

Updated

Rigel Pharmaceuticals' Non-Current Debt came in at $39.24 million for Q2 2026, up 4.8% from $37.45 million a year earlier but down 12.5% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Non-Current Debt (2019 - 2026) Analysis & Trends

At the end of FY2025, Rigel Pharmaceuticals' Non-Current Debt was $52.29 million, down 12.4% from FY2024.

  • Non-Current Debt carries a five-year compound annual growth rate of 21.4% (FY2020 to FY2025).
  • Going back by year, Non-Current Debt was $59.68 million in FY2024 (+14.0%), $52.37 million in FY2023 (+32.8%), $39.45 million in FY2022 (+98.1%) and $19.91 million in FY2021 (+0.5%).
  • The five-year range for quarterly Non-Current Debt is $19.89 million (Q3 2021) to $59.76 million (Q3 2024).
  • Year-over-year, Non-Current Debt increased in three of the last eight quarters, with an average decline of 10.1%.
  • The fastest year-over-year change in Non-Current Debt over five years came in Q2 2023 (growth of 99.7%), and the weakest in Q3 2025 (a decline of 49.9%).
  • Business Quant data shows RIGL's Non-Current Debt at $44.86 million (Q1 2026), $52.29 million (Q4 2025) and $29.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Rigel Pharmaceuticals 922.04 Mn 387.93 Mn 70.18 Mn 39.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.24 Mn
Mar 31, 2026 44.86 Mn
Dec 31, 2025 52.29 Mn
Sep 30, 2025 29.97 Mn
Jun 30, 2025 37.45 Mn
Mar 31, 2025 44.93 Mn
Dec 31, 2024 59.68 Mn
Sep 30, 2024 59.76 Mn
Jun 30, 2024 59.69 Mn
Mar 31, 2024 44.91 Mn
Dec 31, 2023 52.37 Mn
Sep 30, 2023 59.66 Mn
Jun 30, 2023 59.57 Mn
Mar 31, 2023 59.48 Mn
Dec 31, 2022 39.45 Mn
Sep 30, 2022 39.47 Mn
Jun 30, 2022 29.84 Mn
Mar 31, 2022 29.85 Mn
Dec 31, 2021 19.91 Mn
Sep 30, 2021 19.89 Mn
API Access

Rigel Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RIGL&period=max&api_key=YOUR_API_KEY